DOMS Industries Limited has successfully completed its acquisition of a 51.77% equity stake in Uniclan Healthcare Private Limited, marking its strategic entry into the fast-growing baby hygiene products market. The acquisition involves the purchase of 71,16,080 equity shares for a total consideration of ₹54.88 crore, with ₹28.88 crore allocated for capacity expansion, debt repayment, and working capital for Uniclan.

This acquisition significantly boosts DOMS’ product portfolio, allowing it to expand beyond its established stationery and art material market. By adding Uniclan’s baby diapers, wipes, and other hygiene products to its offering, DOMS is positioning itself for accelerated growth in a sector that is projected to grow at a CAGR of 16%. Uniclan's flagship brand, "Wowper", is already gaining traction with consumers, and its state-of-the-art manufacturing facility in Jaipur, Rajasthan, boasts an installed capacity of 400 million pull-up pant-style diapers per annum.

Commenting on the acquisition, Mr. Santosh Raveshia, Managing Director of DOMS, said, "This acquisition of Uniclan Healthcare is a vital step in our broader strategy to diversify and tap into the baby hygiene market, which complements our focus on children's growth years. With Uniclan’s focus on innovation and DOMS' established distribution network, we expect to unlock new opportunities and strengthen both brands’ market presence."

For Uniclan, the partnership with DOMS provides unparalleled access to DOMS’ super stockists and distributors, both in India and in over 50 countries globally, including markets across Asia, Africa, Europe, and the Middle East. Uniclan’s Founder and Director, Mr. Vatsal Desai, expressed confidence in the partnership, noting that the collaboration will accelerate Uniclan’s growth trajectory by leveraging DOMS’ extensive consumer base and market expertise.

With this acquisition, DOMS gains access to a ₹2 billion diaper market, and over time, Uniclan’s distribution network could also serve as a parallel channel for DOMS' stationery and art products. The synergy between the two companies promises to bring innovation and mutual success, driven by DOMS' leadership in product quality and Uniclan's commitment to delivering exceptional baby hygiene products.

Explore more about DOMS’ growth strategy and future plans on the Top News Headlines or learn about the latest IPOs to apply now.

For expert insights on stock trading and financial markets, join Trading with CA Abhay Telegram Channel or stay updated with market trends through Finance Saathi Telegram Channel.

Ready to invest in upcoming IPOs? Open a free demat account with Choice Broking FinX and get started with ease.

DOMS’ acquisition of Uniclan Healthcare represents a critical step in diversifying its business portfolio while enhancing its long-term growth strategy. The collaboration between the two companies is poised to set new benchmarks in the baby hygiene industry, delivering quality products backed by robust R&D and distribution.